EUVIMEDEUVIMED entdecken
Crossref

Possibility of Human Embryo Genome Editing Continues to be Debated

K. S. Sharov

Онтогенез / Russian Journal of Developmental Biology · 2025

DOI: 10.7868/s3034626625020021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Онтогенез / Russian Journal of Developmental Biology, 2025. Verfasst von K. S. Sharov.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2021, the International Society for Stem Cell Research (ISSCR) cancelled the famous “Rule of 14 days” that has been regulating research on human embryos. This led to the emergence of novel controversial problems in bioethics, which are related to prospects of human genome editing in embryo. Theoretically, one can treat more than ten thousand inherited diseases with the use of gene editing techniques. Practically, these techniques have already been applied for treating a number of adults’ diseases. However, therapy based on gene editing technologies did not always lead to positive effects. Moreover, one may ask, whether these techniques can be used for gene editing of human embryos and gametes so that healthy children would be born that would have hereditary diseases otherwise. In this brief communication, we consider arguments “in favour” and “against”. We conclude that risks overweigh the potential good at this stage of gene editing techniques development.

Zitieren

APA

Sharov, K. S. (2025). Possibility of Human Embryo Genome Editing Continues to be Debated. Онтогенез / Russian Journal of Developmental Biology. https://doi.org/10.7868/s3034626625020021

Vancouver

Sharov KS. Possibility of Human Embryo Genome Editing Continues to be Debated. Онтогенез / Russian Journal of Developmental Biology. 2025. doi:10.7868/s3034626625020021

BibTeX
@article{Sharov2025,
  author = {Sharov, K. S.},
  title = {Possibility of Human Embryo Genome Editing Continues to be Debated},
  journal = {Онтогенез / Russian Journal of Developmental Biology},
  year = {2025},
  doi = {10.7868/s3034626625020021}
}
Kostenlos starten →